Powered by vBulletin

Legendary Castithan Sweeper

Printable View

  • 12-30-2013, 12:33 AM
    CEOIII
    Legendary Castithan Sweeper
    3162 EGO
    Cannoneer Synergy
    x0.95 reload
    x1.15 melee dmg
    x1.15 melee dmg (yes, the gun has it twice)
    25% of clip reloaded on melee kill
    x1.15 crit multi

    Not really looking for anything, plus I HATE shotguns, so.....1st come, 1st serve.
  • 12-30-2013, 01:11 PM
    CBeezy
    What's your ego?
  • 12-30-2013, 01:40 PM
    orchido
    How do you feel about pistols (e.g. Monitor Sidearm) or infectors (e.g. Corpse Infector)?
  • 12-30-2013, 09:30 PM
    CEOIII
    Quote:

    Originally Posted by orchido View Post
    How do you feel about pistols (e.g. Monitor Sidearm) or infectors (e.g. Corpse Infector)?

    Pistols I like (wouldn't mind a better wolfhound or a thunderer). Infectors I wouldn't piss on if they were on fire.
  • 12-30-2013, 09:36 PM
    CEOIII
    And just as an aside: Shouldn't I be getting emails when someone replies to this thread? I haven't gotten an email about this forum since the beta.
  • 12-30-2013, 10:06 PM
    bigdawg21180
    U have to subscribe to a thread to get the notification emails
  • 12-30-2013, 11:19 PM
    CEOIII
    I STARTED THIS THREAD. I'm already subscribed to it.
  • 12-30-2013, 11:40 PM
    bigdawg21180
    I realize that as it says that u did but it's not the same thing. Go to thread tools and click subscribe then u will get the conformations
  • 12-30-2013, 11:52 PM
    CEOIII
    All it says is "unsubscribe from this thread".
  • 12-31-2013, 01:15 AM
    bigdawg21180
    Ok then go into ur settings and click subscriptions and where u see ur thread click on instant notification(or something like that)
  • 12-31-2013, 12:04 PM
    CBeezy
    I have and ego 4020 monitor sidearm, and others weapons a tad bit lower, whats you psn or ign?
  • 12-31-2013, 06:24 PM
    CEOIII
    In my sig.
All times are GMT -7. The time now is 10:30 AM.
Powered by vBulletin™ Version 4.1.3
Copyright © 2021 vBulletin Solutions, Inc. All rights reserved.